These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 16167009)

  • 41. Drug insight: New antiemetics in the management of chemotherapy-induced nausea and vomiting.
    Oo TH; Hesketh PJ
    Nat Clin Pract Oncol; 2005 Apr; 2(4):196-201. PubMed ID: 16264934
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fosaprepitant: a neurokinin-1 receptor antagonist for the prevention of chemotherapy-induced nausea and vomiting.
    Navari RM
    Expert Rev Anticancer Ther; 2008 Nov; 8(11):1733-42. PubMed ID: 18983233
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effects of antiemetics for children with vomiting due to acute, moderate gastroenteritis.
    Vreeman RC; Finnell SM; Cernkovich ER; Carroll AE
    Arch Pediatr Adolesc Med; 2008 Sep; 162(9):866-9. PubMed ID: 18762605
    [No Abstract]   [Full Text] [Related]  

  • 44. Palonosetron plus dexamethasone effectively prevents acute and delayed chemotherapy-induced nausea and vomiting following highly or moderately emetogenic chemotherapy in pre-treated patients who have failed to respond to a previous antiemetic treatment: comparison between elderly and non-elderly patient response.
    Massa E; Astara G; Madeddu C; Dessì M; Loi C; Lepori S; Mantovani G
    Crit Rev Oncol Hematol; 2009 Apr; 70(1):83-91. PubMed ID: 18723369
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antiemetic study methodology: recommendations for future studies.
    Olver IN
    Oncology; 1996 Jun; 53 Suppl 1():96-101. PubMed ID: 8692560
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Management of radiation-induced nausea and vomiting.
    Abdelsayed GG
    Exp Hematol; 2007 Apr; 35(4 Suppl 1):34-6. PubMed ID: 17379085
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparative activity of antiemetic drugs.
    Jordan K; Schmoll HJ; Aapro MS
    Crit Rev Oncol Hematol; 2007 Feb; 61(2):162-75. PubMed ID: 17208005
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antiemetics for acute gastroenteritis in children.
    Levine DA
    Curr Opin Pediatr; 2009 Jun; 21(3):294-8. PubMed ID: 19381093
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Infusion of palonosetron plus dexamethasone for the prevention of chemotherapy-induced nausea and vomiting.
    Hajdenberg J; Grote T; Yee L; Arevalo-Araujo R; Latimer LA
    J Support Oncol; 2006 Oct; 4(9):467-71. PubMed ID: 17080735
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Haloperidol versus ondansetron for prophylaxis of postoperative nausea and vomiting.
    Rosow CE; Haspel KL; Smith SE; Grecu L; Bittner EA
    Anesth Analg; 2008 May; 106(5):1407-9, table of contents. PubMed ID: 18420852
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transdermal patch tailors antinausea treatment.
    Morrow T
    Manag Care; 2008 Dec; 17(12):47-8. PubMed ID: 19127767
    [No Abstract]   [Full Text] [Related]  

  • 52. Safety and efficacy of a continuous infusion, patient-controlled antiemetic pump for children receiving emetogenic chemotherapy.
    Jones E; Koyama T; Ho RH; Kuttesch J; Shankar S; Whitlock JA; Cartwright J; Frangoul H
    Pediatr Blood Cancer; 2007 Mar; 48(3):330-2. PubMed ID: 16304666
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Meta-analysis: ondansetron for vomiting in acute gastroenteritis in children.
    Szajewska H; Gieruszczak-Białek D; Dylag M
    Aliment Pharmacol Ther; 2007 Feb; 25(4):393-400. PubMed ID: 17269994
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evolving roles of oncology pharmacists in Singapore: a survey on prescribing patterns of antiemetics for chemotherapy induced nausea and vomiting (CINV) at a cancer centre.
    Chan A; Shih V; Chew L
    J Oncol Pharm Pract; 2008 Mar; 14(1):23-9. PubMed ID: 18337437
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The pigeon as an object for evaluating the activity of substances in vomiting of different origins].
    Naletov SV; Klimchuk TI; Komissarov IV
    Eksp Klin Farmakol; 1993; 56(4):60-1. PubMed ID: 8220022
    [No Abstract]   [Full Text] [Related]  

  • 56. A randomized, double-blind comparison of the NK1 antagonist, aprepitant, versus ondansetron for the prevention of postoperative nausea and vomiting.
    Gan TJ; Apfel CC; Kovac A; Philip BK; Singla N; Minkowitz H; Habib AS; Knighton J; Carides AD; Zhang H; Horgan KJ; Evans JK; Lawson FC;
    Anesth Analg; 2007 May; 104(5):1082-9, tables of contents. PubMed ID: 17456656
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Management of platinum-based chemotherapy-induced acute nausea and vomiting: is there a superior serotonin receptor antagonist?
    Hamadani M; Chaudhary L; Awan FT; Khan JK; Kojouri K; Ozer H; Tfayli A
    J Oncol Pharm Pract; 2007 Jun; 13(2):69-75. PubMed ID: 17873106
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Don't overlook emesis not caused by chemotherapy.
    J Support Oncol; 2006 Feb; 4(2):80-1. PubMed ID: 16502523
    [No Abstract]   [Full Text] [Related]  

  • 59. [Nausea and vomiting in oncologic therapy. Guidelines for use of setrone].
    Nemec K
    Pharm Unserer Zeit; 2007; 36(5):362-7. PubMed ID: 17722163
    [No Abstract]   [Full Text] [Related]  

  • 60. Antiemetics for children with gastroenteritis: off-label but still on in clinical practice.
    Albano F; Bruzzese E; Spagnuolo MI; De Marco G
    J Pediatr Gastroenterol Nutr; 2006 Sep; 43(3):402-4. PubMed ID: 16954969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.